List your company

HER2 status prediction on Breast cancer H2 (internal cohort)

0.8412Mean AUCLiteFM
0.7094320.7436410.777850.812059Feb 15, 2026

Evaluation results

MethodLinks
LiteFMModel=LiteFM2026.020.8412
LitePathModel=LitePath2026.020.8409
LiteFM-LModel=LiteFM-L2026.020.8362
GPFMModel=GPFM2026.020.8358
LiteFM-SModel=LiteFM-S2026.020.8336
LiteVirchow2Model=LiteVirchow22026.020.8332
H-Optimus-1Model=H-Optimus-12026.020.8286
Prov-GigaPathModel=Prov-GigaPath2026.020.8284
Phikon2Model=Phikon22026.020.8278
Virchow2Model=Virchow22026.020.8264
VirchowModel=Virchow2026.020.82
CTransPathModel=CTransPath2026.020.8192
mSTARModel=mSTAR2026.020.8188
UNIModel=UNI2026.020.8176
UNI2Model=UNI22026.020.8162
PhikonModel=Phikon2026.020.8141
CONCHModel=CONCH2026.020.8041
CHIEFModel=CHIEF2026.020.8031
MUSKModel=MUSK2026.020.8013
PLIPModel=PLIP2026.020.7983
CONCH1.5Model=CONCH1.52026.020.7976
Hibou-LModel=Hibou-L2026.020.7796
Resnet50Model=Resnet502026.020.7145